Skip to main content

Advertisement

Log in

TransgenicLycium barbarum L. Established as HIV capsid protein expression system

  • Protocols
  • Published:
Plant Molecular Biology Reporter Aims and scope Submit manuscript

Abstract

A DNA fragment (MA4-CA) encoding HIV CA viral like particles (VLPs) was transferred intoLycium barbarum L. byAgrobacterium tumefaciens-mediated transformation. PCR amplification analysis of DNA from transgenic plants confirmed the presence of the fusion gene under the control of promoter p35S. CA protein was identified in transformed leaf extracts by enzyme-linked immunosorbent assay (ELISA), indicating that a transgenicLycium barbarum L. expression system can produce immunogenic CA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CA:

capsid

VLPs:

virus-like particles

MA4-CA:

matrix-capsid fusion protein

References

  • Benson EM, Clarkson J, Law M, Marshall P, Kelleher AD, Smith DE, Patou G, Stewart GJ, Cooper DA, and French RA (1999) Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals. AIDS Res Human Retroviruses 15: 105–113.

    Article  CAS  Google Scholar 

  • Daniell H, Streatfield SJ, and Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6: 219–226.

    Article  PubMed  CAS  Google Scholar 

  • Du LQ, Wang HZ, Huang FC, Li AS, and Shao QQ (1994) Genetic transformation ofLycium barbarum L. viaA. tumefaciens. Sci China B 37: 286–292.

    PubMed  CAS  Google Scholar 

  • Hood EE, Woodard SL, and Horn ME (2002) Monoclonal antibody manufacturing in transgenic plants—myths and realities. Curr Opin Biotechnol 13: 630–635.

    Article  PubMed  CAS  Google Scholar 

  • Kapusta J, Modelska A, Figlerowicz M, Pniewski T, Letellier M, Lisowa O, Yusibov V, Koprowski H, Plucienniczak A, and Legocki AB (1999) A plant-derived edible vaccine against hepatitis B virus. FASEB J 13: 1796–1799.

    PubMed  CAS  Google Scholar 

  • Kusnadi AR, Nikolov ZL, and Ford C (1997) Production of recombinant proteins in transgenic plants: practical considerations. Biotech Biogeng 56: 473–483.

    Article  CAS  Google Scholar 

  • Martin SJ, Vyakarnam A, Cheingsong-Popov R, Callow D, Jones KL, Senior JM, Adams SE, Kingsman AJ, Matear P, Gotch FM, McMichael AJ, Roitt IM, and Weber JN (1993) Immunization of human HIV-seronegative volunteers with recombinant p17/p24: Ty viruslike particles elicits HIV-1 p24-specific cellular and humoral immune responses. AIDS 7: 1315–1323.

    Article  PubMed  CAS  Google Scholar 

  • Montroni M, Silvestri G, Butini L, Bartocci C, Regnery C, and Danieli G (1992) p24 antigenaemia as a predictor of good immunological responsiveness to zidovudine therapy in asymptomatic HIV infection (letter). AIDS 6: 338–339.

    Article  PubMed  CAS  Google Scholar 

  • Reddy MM, Winger EE, Hargrove D, McHugh T, McKinley GF, and Grieco MH (1992) An improved method for monitoring efficacy of anti-retroviral therapy in HIV-infected individuals; a highly sensitive HIV p24 antigen assay. J Clinic Lab Anal 6: 125–129.

    Article  CAS  Google Scholar 

  • Spector SA, Kennedy C, McCutchan JA, Bozzette SA, Straube RG, Connor JD, and Richman DD (1989) The antiviral effect of zidovudine and ribavirin in clinical trails and the use of p24 antigen levels as a virologic marker. J Infect Dis 159: 822–828.

    PubMed  CAS  Google Scholar 

  • Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, and Arntzen CJ (2000) Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182: 302–305.

    Article  PubMed  CAS  Google Scholar 

  • von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, and Sundquist WI (1998) Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J 17: 1555–1568.

    Article  Google Scholar 

  • Warzecha H and Mason HS (2003) Benefis and risk of antibody and vaccine production in transgenic in transgenic plants. J Plant Physiol 160: 755–764.

    Article  PubMed  CAS  Google Scholar 

  • Zhang G, Leung C, Murdin L, Rovinski B, and White KA (2000) In Planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector. Mol Biotechnol 14: 99–107.

    Article  PubMed  CAS  Google Scholar 

  • Zhang GG, Rodrigues L, Rovinski B, and White KA (2002) Production of HIV-1 p24 protein in transgenic tobacco plants. Mol Biotechnol 20: 131–136.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chang-Zheng Song.

Additional information

Supported by the Natural Science Foundation of China, Nos. 30271215 and 30471621

Rights and permissions

Reprints and permissions

About this article

Cite this article

Du, GL., Song, CZ., Zhang, GL. et al. TransgenicLycium barbarum L. Established as HIV capsid protein expression system. Plant Mol Biol Rep 23, 411–416 (2005). https://doi.org/10.1007/BF02788889

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02788889

Key words

Navigation